TradingAgents AISign inGet started
All stock profiles
ONCONASDAQHealthcare

ONCONETIX INC

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$0.56

-4.27%

Alpha Vantage · 10/30/2026

Industry: BiotechnologyCategory: Domestic Common StockCurrency: USDNews: 0 recent
Analyze ONCO free

One-year price history

Adjusted daily closes · 252 observations · as of Oct 30, 2026

Historical data, not a forecast

1 month

-24.6%

3 months

-30.8%

6 months

-91.2%

1 year

-99.7%

Year to date

-99.3%

52-week range

$0.40 – $189.50

Fundamental snapshot

Latest reported period: Jun 30, 2026

Sharadar reported data

Market cap

$2.2M

P/E

-0.2

P/B

0.2

P/S

3.4

Revenue

$645.82K

Net income

-$10.2M

Diluted EPS

248.72

Gross margin

80.40%

Net margin

-1578.80%

Return on equity

-92.00%

Total debt

$187.13K

Cash

$5.94M

Free cash flow

-$10.31M

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Jun 30, 2026$17.12K-$2.87M25.10%-16748.30%-$1.92M
Mar 31, 2026$21.46K-$4.21M-7.70%-19643.40%-$2.12M
Dec 31, 2025$303.6K$5.67M81.60%1867.50%-$3.09M
Sep 30, 2025$303.65K-$8.78M88.60%-2892.70%-$3.18M
Jun 30, 2025$106.49K-$2.37M66.20%-2536.20%-$1.41M
Mar 31, 2025$101.63K-$8.55M45.10%-9560.10%-$2M
Dec 31, 2024$711.98K-$29.44M92.70%-4163.70%-$921.52K
Sep 30, 2024$406.86K-$3.83M25.90%-940.70%-$1.15M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent ONCO news

All market news

No ticker-linked stories are in the current archive.